APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alpha Synuclein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Alpha Synuclein Industry Growth and Trends Forecast to 2032

19 December 2025107 pages

Choose your research edition.

Industry ResearchAlpha Synuclein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha Synuclein Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Alpha Synuclein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha Synuclein Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha Synuclein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Alpha Synuclein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha Synuclein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alpha Synuclein include Biogen Inc, reMYND NV, QR Pharma Inc, Prothena Corp Plc, nLife Therapeutics SL, Neuropore Therapies Inc, MedImmune LLC, ICB International Inc and H. Lundbeck A/S, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Alpha Synuclein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Alpha Synuclein market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Alpha Synuclein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Alpha Synuclein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Alpha Synuclein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Alpha Synuclein Market by Company

Biogen Inc

reMYND NV

QR Pharma Inc

Prothena Corp Plc

nLife Therapeutics SL

Neuropore Therapies Inc

MedImmune LLC

ICB International Inc

H. Lundbeck A/S

Genmab A/S

Evotec AG

BioArctic AB

AFFiRiS AG

AC Immune SA

Alpha Synuclein Segment by Type

DPC-003

BIIB-054

BAN-0805

AV-1950R

AV-1947D

Others

Alpha Synuclein Segment by Application

Multiple System Atrophy

Lewy Body Dementia

Neurodegenerateive Disease

Others

Alpha Synuclein Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha Synuclein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha Synuclein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha Synuclein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alpha Synuclein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Alpha Synuclein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DPC-003 Table 2. Major Company of BIIB-054 Table 3. Major Company of BAN-0805 Table 4. Major Company of AV-1950R Table 5. Major Company of AV-1947D Table 6. Major Company of Others Table 7. Global Alpha Synuclein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 9. Global Alpha Synuclein Sales Market Share in Volume by Type (2021-2026) Table 10. Global Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 11. Global Alpha Synuclein Sales Market Share in Value by Type (2021-2026) Table 12. Global Alpha Synuclein Price by Type (2021-2026) & (US$/Unit) Table 13. Global Alpha Synuclein Sales by Type (2027-2032) & (K Units) Table 14. Global Alpha Synuclein Sales Market Share in Volume by Type (2027-2032) Table 15. Global Alpha Synuclein Sales by Type (2027-2032) & (US$ Million) Table 16. Global Alpha Synuclein Sales Market Share in Value by Type (2027-2032) Table 17. Global Alpha Synuclein Price by Type (2027-2032) & (US$/Unit) Table 18. North America Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 19. North America Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 21. Europe Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 25. Latin America Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Alpha Synuclein Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Alpha Synuclein Sales by Type (2021-2026) & (US$ Million) Table 28. Alpha Synuclein Industry Trends Table 29. Alpha Synuclein Industry Drivers Table 30. Alpha Synuclein Industry Opportunities and Challenges Table 31. Alpha Synuclein Industry Restraints Table 32. Global Alpha Synuclein Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Alpha Synuclein Revenue Market Share by Company (2021-2026) Table 34. Global Alpha Synuclein Sales by Company (2021-2026) & (K Units) Table 35. Global Alpha Synuclein Sales Share by Company (2021-2026) Table 36. Global Alpha Synuclein Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Alpha Synuclein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Alpha Synuclein Major Company Production Sites and Headquarters Table 39. Global Alpha Synuclein Company, Product Type & Application Table 40. Global Alpha Synuclein Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Alpha Synuclein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Alpha Synuclein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Alpha Synuclein Sales by Region (2021-2026) & (K Units) Table 45. Global Alpha Synuclein Sales Market Share in Volume by Region (2021-2026) Table 46. Global Alpha Synuclein Sales by Region (2021-2026) & (US$ Million) Table 47. Global Alpha Synuclein Sales Market Share in Value by Region (2021-2026) Table 48. Global Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Alpha Synuclein Sales by Region (2027-2032) & (K Units) Table 50. Global Alpha Synuclein Sales Market Share in Volume by Region (2027-2032) Table 51. Global Alpha Synuclein Sales by Region (2027-2032) & (US$ Million) Table 52. Global Alpha Synuclein Sales Market Share in Value by Region (2027-2032) Table 53. Global Alpha Synuclein Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Alpha Synuclein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 56. Global Alpha Synuclein Sales Market Share in Volume by Application (2021-2026) Table 57. Global Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 58. Global Alpha Synuclein Sales Market Share in Value by Application (2021-2026) Table 59. Global Alpha Synuclein Price by Application (2021-2026) & (US$/Unit) Table 60. Global Alpha Synuclein Sales by Application (2027-2032) & (K Units) Table 61. Global Alpha Synuclein Sales Market Share in Volume by Application (2027-2032) Table 62. Global Alpha Synuclein Sales by Application (2027-2032) & (US$ Million) Table 63. Global Alpha Synuclein Sales Market Share in Value by Application (2027-2032) Table 64. Global Alpha Synuclein Price by Application (2027-2032) & (US$/Unit) Table 65. North America Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 66. North America Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 68. Europe Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 72. Latin America Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Alpha Synuclein Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Alpha Synuclein Sales by Application (2021-2026) & (US$ Million) Table 75. Biogen Inc Company Information Table 76. Biogen Inc Business Overview Table 77. Biogen Inc Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Biogen Inc Alpha Synuclein Product Portfolio Table 79. Biogen Inc Recent Development Table 80. reMYND NV Company Information Table 81. reMYND NV Business Overview Table 82. reMYND NV Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. reMYND NV Alpha Synuclein Product Portfolio Table 84. reMYND NV Recent Development Table 85. QR Pharma Inc Company Information Table 86. QR Pharma Inc Business Overview Table 87. QR Pharma Inc Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. QR Pharma Inc Alpha Synuclein Product Portfolio Table 89. QR Pharma Inc Recent Development Table 90. Prothena Corp Plc Company Information Table 91. Prothena Corp Plc Business Overview Table 92. Prothena Corp Plc Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Prothena Corp Plc Alpha Synuclein Product Portfolio Table 94. Prothena Corp Plc Recent Development Table 95. nLife Therapeutics SL Company Information Table 96. nLife Therapeutics SL Business Overview Table 97. nLife Therapeutics SL Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. nLife Therapeutics SL Alpha Synuclein Product Portfolio Table 99. nLife Therapeutics SL Recent Development Table 100. Neuropore Therapies Inc Company Information Table 101. Neuropore Therapies Inc Business Overview Table 102. Neuropore Therapies Inc Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Neuropore Therapies Inc Alpha Synuclein Product Portfolio Table 104. Neuropore Therapies Inc Recent Development Table 105. MedImmune LLC Company Information Table 106. MedImmune LLC Business Overview Table 107. MedImmune LLC Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. MedImmune LLC Alpha Synuclein Product Portfolio Table 109. MedImmune LLC Recent Development Table 110. ICB International Inc Company Information Table 111. ICB International Inc Business Overview Table 112. ICB International Inc Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. ICB International Inc Alpha Synuclein Product Portfolio Table 114. ICB International Inc Recent Development Table 115. H. Lundbeck A/S Company Information Table 116. H. Lundbeck A/S Business Overview Table 117. H. Lundbeck A/S Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. H. Lundbeck A/S Alpha Synuclein Product Portfolio Table 119. H. Lundbeck A/S Recent Development Table 120. Genmab A/S Company Information Table 121. Genmab A/S Business Overview Table 122. Genmab A/S Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Genmab A/S Alpha Synuclein Product Portfolio Table 124. Genmab A/S Recent Development Table 125. Evotec AG Company Information Table 126. Evotec AG Business Overview Table 127. Evotec AG Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Evotec AG Alpha Synuclein Product Portfolio Table 129. Evotec AG Recent Development Table 130. BioArctic AB Company Information Table 131. BioArctic AB Business Overview Table 132. BioArctic AB Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. BioArctic AB Alpha Synuclein Product Portfolio Table 134. BioArctic AB Recent Development Table 135. AFFiRiS AG Company Information Table 136. AFFiRiS AG Business Overview Table 137. AFFiRiS AG Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. AFFiRiS AG Alpha Synuclein Product Portfolio Table 139. AFFiRiS AG Recent Development Table 140. AC Immune SA Company Information Table 141. AC Immune SA Business Overview Table 142. AC Immune SA Alpha Synuclein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. AC Immune SA Alpha Synuclein Product Portfolio Table 144. AC Immune SA Recent Development Table 145. North America Alpha Synuclein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. North America Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 147. North America Alpha Synuclein Sales Market Share by Country (2021-2026) Table 148. North America Alpha Synuclein Sales Forecast by Country (2027-2032) & (K Units) Table 149. North America Alpha Synuclein Sales Market Share Forecast by Country (2027-2032) Table 150. North America Alpha Synuclein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. North America Alpha Synuclein Market Size by Country (2021-2026) & (US$ Million) Table 152. North America Alpha Synuclein Market Share by Country (2021-2026) Table 153. North America Alpha Synuclein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. North America Alpha Synuclein Market Share Forecast by Country (2027-2032) Table 155. Europe Alpha Synuclein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Europe Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 157. Europe Alpha Synuclein Sales Market Share by Country (2021-2026) Table 158. Europe Alpha Synuclein Sales Forecast by Country (2027-2032) & (K Units) Table 159. Europe Alpha Synuclein Sales Market Share Forecast by Country (2027-2032) Table 160. Europe Alpha Synuclein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Europe Alpha Synuclein Market Size by Country (2021-2026) & (US$ Million) Table 162. Europe Alpha Synuclein Market Share by Country (2021-2026) Table 163. Europe Alpha Synuclein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Europe Alpha Synuclein Market Share Forecast by Country (2027-2032) Table 165. Asia-Pacific Alpha Synuclein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Asia-Pacific Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 167. Asia-Pacific Alpha Synuclein Sales Market Share by Country (2021-2026) Table 168. Asia-Pacific Alpha Synuclein Sales Forecast by Country (2027-2032) & (K Units) Table 169. Asia-Pacific Alpha Synuclein Sales Market Share Forecast by Country (2027-2032) Table 170. Asia-Pacific Alpha Synuclein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Asia-Pacific Alpha Synuclein Market Size by Country (2021-2026) & (US$ Million) Table 172. Asia-Pacific Alpha Synuclein Market Share by Country (2021-2026) Table 173. Asia-Pacific Alpha Synuclein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Asia-Pacific Alpha Synuclein Market Share Forecast by Country (2027-2032) Table 175. Latin America Alpha Synuclein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 176. Latin America Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 177. Latin America Alpha Synuclein Sales Market Share by Country (2021-2026) Table 178. Latin America Alpha Synuclein Sales Forecast by Country (2027-2032) & (K Units) Table 179. Latin America Alpha Synuclein Sales Market Share Forecast by Country (2027-2032) Table 180. Latin America Alpha Synuclein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Latin America Alpha Synuclein Market Size by Country (2021-2026) & (US$ Million) Table 182. Latin America Alpha Synuclein Market Share by Country (2021-2026) Table 183. Latin America Alpha Synuclein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Latin America Alpha Synuclein Market Share Forecast by Country (2027-2032) Table 185. Middle East and Africa Alpha Synuclein Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. Middle East and Africa Alpha Synuclein Sales by Country (2021-2026) & (K Units) Table 187. Middle East and Africa Alpha Synuclein Sales Market Share by Country (2021-2026) Table 188. Middle East and Africa Alpha Synuclein Sales Forecast by Country (2027-2032) & (K Units) Table 189. Middle East and Africa Alpha Synuclein Sales Market Share Forecast by Country (2027-2032) Table 190. Middle East and Africa Alpha Synuclein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. Middle East and Africa Alpha Synuclein Market Size by Country (2021-2026) & (US$ Million) Table 192. Middle East and Africa Alpha Synuclein Market Share by Country (2021-2026) Table 193. Middle East and Africa Alpha Synuclein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. Middle East and Africa Alpha Synuclein Market Share Forecast by Country (2027-2032) Table 195. Key Raw Materials Table 196. Raw Materials Key Suppliers Table 197. Alpha Synuclein Distributors List Table 198. Alpha Synuclein Customers List Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Alpha Synuclein Image Figure 2. Global Alpha Synuclein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha Synuclein Market Size (2021-2032) & (US$ Million) Figure 4. Global Alpha Synuclein Sales (2021-2032) & (K Units) Figure 5. DPC-003 Image Figure 6. Global DPC-003 Sales YoY Growth (2021-2032) & (K Units) Figure 7. BIIB-054 Image Figure 8. Global BIIB-054 Sales YoY Growth (2021-2032) & (K Units) Figure 9. BAN-0805 Image Figure 10. Global BAN-0805 Sales YoY Growth (2021-2032) & (K Units) Figure 11. AV-1950R Image Figure 12. Global AV-1950R Sales YoY Growth (2021-2032) & (K Units) Figure 13. AV-1947D Image Figure 14. Global AV-1947D Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Alpha Synuclein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Alpha Synuclein Market Share by Type 2025 VS 2032 Figure 19. North America Alpha Synuclein Sales Market Share in Volume by Type in 2025 Figure 20. North America Alpha Synuclein Sales Market Share in Value by Type in 2025 Figure 21. Europe Alpha Synuclein Sales Market Share in Volume by Type in 2025 Figure 22. Europe Alpha Synuclein Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Alpha Synuclein Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Alpha Synuclein Sales Market Share in Value by Type in 2025 Figure 25. Latin America Alpha Synuclein Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Alpha Synuclein Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Alpha Synuclein Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Alpha Synuclein Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Alpha Synuclein Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Multiple System Atrophy Image Figure 32. Global Multiple System Atrophy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Lewy Body Dementia Image Figure 34. Global Lewy Body Dementia Sales YoY Growth (2021-2032) & (K Units) Figure 35. Neurodegenerateive Disease Image Figure 36. Global Neurodegenerateive Disease Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Alpha Synuclein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Alpha Synuclein Market Share by Application 2025 VS 2032 Figure 41. North America Alpha Synuclein Sales Market Share in Volume by Application in 2025 Figure 42. North America Alpha Synuclein Sales Market Share in Value by Application in 2025 Figure 43. Europe Alpha Synuclein Sales Market Share in Volume by Application in 2025 Figure 44. Europe Alpha Synuclein Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Alpha Synuclein Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Alpha Synuclein Sales Market Share in Value by Application in 2025 Figure 47. Latin America Alpha Synuclein Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Alpha Synuclein Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Alpha Synuclein Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Alpha Synuclein Sales Market Share in Value by Application in 2025 Figure 51. North America Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Alpha Synuclein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Alpha Synuclein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Alpha Synuclein Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Alpha Synuclein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Alpha Synuclein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Alpha Synuclein Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Alpha Synuclein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Alpha Synuclein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Alpha Synuclein Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Alpha Synuclein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Alpha Synuclein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Alpha Synuclein Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Alpha Synuclein Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Alpha Synuclein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Alpha Synuclein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Alpha Synuclein Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Alpha Synuclein Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Alpha Synuclein Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • DPC-003
  • BIIB-054
  • BAN-0805
  • AV-1950R
  • AV-1947D
  • Others
Applications
  • Multiple System Atrophy
  • Lewy Body Dementia
  • Neurodegenerateive Disease
  • Others
Companies covered
  • Biogen Inc
  • reMYND NV
  • QR Pharma Inc
  • Prothena Corp Plc
  • nLife Therapeutics SL
  • Neuropore Therapies Inc
  • MedImmune LLC
  • ICB International Inc
  • H. Lundbeck A/S
  • Genmab A/S
  • Evotec AG
  • BioArctic AB
  • AFFiRiS AG
  • AC Immune SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha Synuclein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Alpha Synuclein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Alpha Synuclein Market by Type
  6. 1.3.1 DPC-003
  7. 1.3.2 BIIB-054
  8. 1.3.3 BAN-0805
  9. 1.3.4 AV-1950R
  10. 1.3.5 AV-1947D
  11. 1.3.6 Others
  12. 1.4 Global Alpha Synuclein Market Size by Type
  13. 1.4.1 Global Alpha Synuclein Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Alpha Synuclein Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Alpha Synuclein Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Alpha Synuclein Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Alpha Synuclein Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Alpha Synuclein Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Alpha Synuclein Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Alpha Synuclein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Alpha Synuclein Industry Trends
  2. 2.2 Alpha Synuclein Industry Drivers
  3. 2.3 Alpha Synuclein Industry Opportunities and Challenges
  4. 2.4 Alpha Synuclein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Alpha Synuclein Revenue (2021-2026)
  2. 3.2 Global Top Players by Alpha Synuclein Sales (2021-2026)
  3. 3.3 Global Top Players by Alpha Synuclein Price (2021-2026)
  4. 3.4 Global Alpha Synuclein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alpha Synuclein Major Company Production Sites & Headquarters
  6. 3.6 Global Alpha Synuclein Company, Product Type & Application
  7. 3.7 Global Alpha Synuclein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alpha Synuclein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alpha Synuclein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alpha Synuclein Tier 1, Tier 2, and Tier 3
4 Alpha Synuclein Regional Status and Outlook
  1. 4.1 Global Alpha Synuclein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Alpha Synuclein Historic Market Size by Region
  3. 4.2.1 Global Alpha Synuclein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Alpha Synuclein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Alpha Synuclein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Alpha Synuclein Forecasted Market Size by Region
  7. 4.3.1 Global Alpha Synuclein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Alpha Synuclein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Alpha Synuclein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Alpha Synuclein by Application
  1. 5.1 Alpha Synuclein Market by Application
  2. 5.1.1 Multiple System Atrophy
  3. 5.1.2 Lewy Body Dementia
  4. 5.1.3 Neurodegenerateive Disease
  5. 5.1.4 Others
  6. 5.2 Global Alpha Synuclein Market Size by Application
  7. 5.2.1 Global Alpha Synuclein Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Alpha Synuclein Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Alpha Synuclein Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Alpha Synuclein Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Alpha Synuclein Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Alpha Synuclein Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Alpha Synuclein Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Alpha Synuclein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biogen Inc
  2. 6.1.1 Biogen Inc Company Information
  3. 6.1.2 Biogen Inc Business Overview
  4. 6.1.3 Biogen Inc Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biogen Inc Alpha Synuclein Product Portfolio
  6. 6.1.5 Biogen Inc Recent Developments
  7. 6.2 reMYND NV
  8. 6.2.1 reMYND NV Company Information
  9. 6.2.2 reMYND NV Business Overview
  10. 6.2.3 reMYND NV Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 reMYND NV Alpha Synuclein Product Portfolio
  12. 6.2.5 reMYND NV Recent Developments
  13. 6.3 QR Pharma Inc
  14. 6.3.1 QR Pharma Inc Company Information
  15. 6.3.2 QR Pharma Inc Business Overview
  16. 6.3.3 QR Pharma Inc Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 QR Pharma Inc Alpha Synuclein Product Portfolio
  18. 6.3.5 QR Pharma Inc Recent Developments
  19. 6.4 Prothena Corp Plc
  20. 6.4.1 Prothena Corp Plc Company Information
  21. 6.4.2 Prothena Corp Plc Business Overview
  22. 6.4.3 Prothena Corp Plc Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prothena Corp Plc Alpha Synuclein Product Portfolio
  24. 6.4.5 Prothena Corp Plc Recent Developments
  25. 6.5 nLife Therapeutics SL
  26. 6.5.1 nLife Therapeutics SL Company Information
  27. 6.5.2 nLife Therapeutics SL Business Overview
  28. 6.5.3 nLife Therapeutics SL Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 nLife Therapeutics SL Alpha Synuclein Product Portfolio
  30. 6.5.5 nLife Therapeutics SL Recent Developments
  31. 6.6 Neuropore Therapies Inc
  32. 6.6.1 Neuropore Therapies Inc Company Information
  33. 6.6.2 Neuropore Therapies Inc Business Overview
  34. 6.6.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neuropore Therapies Inc Alpha Synuclein Product Portfolio
  36. 6.6.5 Neuropore Therapies Inc Recent Developments
  37. 6.7 MedImmune LLC
  38. 6.7.1 MedImmune LLC Company Information
  39. 6.7.2 MedImmune LLC Business Overview
  40. 6.7.3 MedImmune LLC Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MedImmune LLC Alpha Synuclein Product Portfolio
  42. 6.7.5 MedImmune LLC Recent Developments
  43. 6.8 ICB International Inc
  44. 6.8.1 ICB International Inc Company Information
  45. 6.8.2 ICB International Inc Business Overview
  46. 6.8.3 ICB International Inc Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ICB International Inc Alpha Synuclein Product Portfolio
  48. 6.8.5 ICB International Inc Recent Developments
  49. 6.9 H. Lundbeck A/S
  50. 6.9.1 H. Lundbeck A/S Company Information
  51. 6.9.2 H. Lundbeck A/S Business Overview
  52. 6.9.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 H. Lundbeck A/S Alpha Synuclein Product Portfolio
  54. 6.9.5 H. Lundbeck A/S Recent Developments
  55. 6.10 Genmab A/S
  56. 6.10.1 Genmab A/S Company Information
  57. 6.10.2 Genmab A/S Business Overview
  58. 6.10.3 Genmab A/S Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Genmab A/S Alpha Synuclein Product Portfolio
  60. 6.10.5 Genmab A/S Recent Developments
  61. 6.11 Evotec AG
  62. 6.11.1 Evotec AG Company Information
  63. 6.11.2 Evotec AG Business Overview
  64. 6.11.3 Evotec AG Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Evotec AG Alpha Synuclein Product Portfolio
  66. 6.11.5 Evotec AG Recent Developments
  67. 6.12 BioArctic AB
  68. 6.12.1 BioArctic AB Company Information
  69. 6.12.2 BioArctic AB Business Overview
  70. 6.12.3 BioArctic AB Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BioArctic AB Alpha Synuclein Product Portfolio
  72. 6.12.5 BioArctic AB Recent Developments
  73. 6.13 AFFiRiS AG
  74. 6.13.1 AFFiRiS AG Company Information
  75. 6.13.2 AFFiRiS AG Business Overview
  76. 6.13.3 AFFiRiS AG Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 AFFiRiS AG Alpha Synuclein Product Portfolio
  78. 6.13.5 AFFiRiS AG Recent Developments
  79. 6.14 AC Immune SA
  80. 6.14.1 AC Immune SA Company Information
  81. 6.14.2 AC Immune SA Business Overview
  82. 6.14.3 AC Immune SA Alpha Synuclein Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AC Immune SA Alpha Synuclein Product Portfolio
  84. 6.14.5 AC Immune SA Recent Developments
7 North America by Country
  1. 7.1 North America Alpha Synuclein Sales by Country
  2. 7.1.1 North America Alpha Synuclein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Alpha Synuclein Sales by Country (2021-2026)
  4. 7.1.3 North America Alpha Synuclein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Alpha Synuclein Market Size by Country
  6. 7.2.1 North America Alpha Synuclein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Alpha Synuclein Market Size by Country (2021-2026)
  8. 7.2.3 North America Alpha Synuclein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Alpha Synuclein Sales by Country
  2. 8.1.1 Europe Alpha Synuclein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Alpha Synuclein Sales by Country (2021-2026)
  4. 8.1.3 Europe Alpha Synuclein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Alpha Synuclein Market Size by Country
  6. 8.2.1 Europe Alpha Synuclein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Alpha Synuclein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Alpha Synuclein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Alpha Synuclein Sales by Country
  2. 9.1.1 Asia-Pacific Alpha Synuclein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Alpha Synuclein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Alpha Synuclein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Alpha Synuclein Market Size by Country
  6. 9.2.1 Asia-Pacific Alpha Synuclein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Alpha Synuclein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Alpha Synuclein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Alpha Synuclein Sales by Country
  2. 10.1.1 South America Alpha Synuclein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Alpha Synuclein Sales by Country (2021-2026)
  4. 10.1.3 South America Alpha Synuclein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Alpha Synuclein Market Size by Country
  6. 10.2.1 South America Alpha Synuclein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Alpha Synuclein Market Size by Country (2021-2026)
  8. 10.2.3 South America Alpha Synuclein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Alpha Synuclein Sales by Country
  2. 11.1.1 Middle East and Africa Alpha Synuclein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Alpha Synuclein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Alpha Synuclein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Alpha Synuclein Market Size by Country
  6. 11.2.1 Middle East and Africa Alpha Synuclein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Alpha Synuclein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Alpha Synuclein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Alpha Synuclein Value Chain Analysis
  2. 12.1.1 Alpha Synuclein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Alpha Synuclein Production Mode & Process
  7. 12.2 Alpha Synuclein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Alpha Synuclein Distributors
  10. 12.2.3 Alpha Synuclein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst